🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,328 results for “China SXT Pharmaceuticals” Clear

  1. Remimazolam besylate

    China SXT Pharmaceuticals

    Sedative

    phase 3 small molecule completed

    1 trial

  2. Riociguat

    China SXT Pharmaceuticals

    Chronic Thromboembolic Pulmonary Hypertension

    phase 3 small molecule active

    1 trial

  3. Romiplostim

    China SXT Pharmaceuticals

    Immune Thrombocytopenia

    phase 3 small molecule completed

    1 trial

  4. Roux-en-Y anastomosis

    China SXT Pharmaceuticals

    Gastric Cancer

    phase 3 other active

    1 trial

  5. SARS-CoV-2 Vaccine (Vero Cell), Inactivated

    China SXT Pharmaceuticals

    COVID-19 Pneumonia

    phase 3 mab completed

    1 trial

  6. Sacubitril-Valsartan

    China SXT Pharmaceuticals

    STEMI

    phase 3 small molecule active

    1 trial

  7. Saline (0.9%, sterile, for infusion)

    China SXT Pharmaceuticals

    Pneumocystis Jiroveci Pneumonia

    phase 3 small molecule active

    1 trial

  8. Sirolimus

    China SXT Pharmaceuticals

    Lupus Nephritis

    phase 3 small molecule active

    1 trial

  9. Somatostatin

    China SXT Pharmaceuticals

    Gallbladder Neoplasms

    phase 3 small molecule completed

    1 trial

  10. Sorafenib

    China SXT Pharmaceuticals

    Hepatocellular Carcinoma

    phase 3 small molecule active

    2 trials

  11. Standard First-Line Therapy

    China SXT Pharmaceuticals

    Unresectable Colorectal Cancer

    phase 3 small molecule active

    1 trial

  12. Start antiplatelet monotherapy

    China SXT Pharmaceuticals

    Intracerebral Hemorrhage

    phase 3 small molecule completed

    1 trial

  13. Steroid nasal spray

    China SXT Pharmaceuticals

    Radiation-Induced Mucositis

    phase 3 small molecule active

    1 trial

  14. Subxiphoid uniportal VATS

    China SXT Pharmaceuticals

    Mediastinal Neoplasms

    phase 3 other active

    1 trial

  15. Subxiphoid uniportal VATS

    China SXT Pharmaceuticals

    Lung Neoplasms

    phase 3 other completed

    1 trial

  16. Supportive care+Prednisone

    China SXT Pharmaceuticals

    Minimal Change Disease

    phase 3 small molecule active

    1 trial

  17. Suzhou Sceneray® DBS System

    China SXT Pharmaceuticals

    Opiate Addiction

    phase 3 other active

    1 trial

  18. Systematic oral health education

    China SXT Pharmaceuticals

    Malignant Tumor of Head and/or Neck

    phase 3 other completed

    1 trial

  19. TCM

    China SXT Pharmaceuticals

    Non-small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  20. TPO

    China SXT Pharmaceuticals

    Sepsis

    phase 3 small molecule active

    1 trial

  21. Tacrolimus

    China SXT Pharmaceuticals

    Liver Transplantation

    phase 3 small molecule active

    1 trial

  22. Tacrolimus capsule

    China SXT Pharmaceuticals

    Myasthenia Gravis

    phase 3 small molecule completed

    1 trial

  23. Tacrolimus capsules

    China SXT Pharmaceuticals

    Lupus Nephritis

    phase 3 small molecule completed

    1 trial

  24. Tamoxifen

    China SXT Pharmaceuticals

    Breast Cancer Female

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources